Law360 (July 1, 2004, 12:00 AM EDT) -- A U.S. district court has cleared Barr Laboratories of infringing three patents at the center of the generic drug maker’s challenge involving Aventis’ Allegra blockbuster allergy drug.
The U.S. District Court...
Barr Cleared Of Infringing Three Patents In Allegra Case
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
